Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are on hemodialysis and have been diagnosed with overactive parathyroid glands caused by chronic kidney disease (a condition called secondary hyperparathyroidism), where their treating doctor has planned to give them a medication called Pacitol Injection based on its prescribing guidelines.
- People who have voluntarily signed a written consent form agreeing to have their personal information collected and used, after being given a full explanation of the study's purpose and methods.
- People who are able to understand the study, cooperate with its requirements, and commit to participating until it is completed.
Who may not be able to join:
- People who have previously had an allergic or hypersensitivity reaction to this medication or any of its ingredients.
- People who show signs of having too much vitamin D in their body (vitamin D toxicity).
- People who have high calcium levels in their blood at the time of enrolling in the trial.
- Women who are pregnant or currently breastfeeding.
- People who have a growth on a parathyroid gland (called a parathyroid adenoma) and are scheduled to have surgery to remove it.
- People who have taken part in another clinical trial and received an experimental drug within the 12 weeks before the study's first visit.
- People considered ineligible by the lead doctor or another supervising doctor on the study team.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-2-708-8000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of subjects whose intact parathyroid hormone level applies to the therapeutic area(CKD 5D)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.